PIP4K2A and acute myeloid leukemia: Both PI5P4Kα and PI5P4Kβ are involved in p53-deficient breast cancer and soft tissue sarcomas22,23 and high expression of both PI5P4Kα and PI5P4Kγ associate with unfavourable clinical outcome in AML.24